近日,Hookipa Pharma这家曾经的诺奖转化公司似乎迎来了这家公司的最终结局——退市被股东吉利德收购。我们早先介绍过Hookipa Pharma的一系列经历,如今被吉利德收购似乎也在预料之中。本文将对Hookipa Pharma早先的一系列经历进行梳理和回顾。最初的诺奖光环Hookipa Pharma是一家以沙粒病毒平台技术为核心的Biotech,有着诺奖得主创立公司的光环加持。技术上来说...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.